HIV/AIDS Clinical Care: AIDS Watch

Once-Daily Kaletra Approved for Treatment-Naive Patients

• HIV/AIDS Clinical Care
• AIDS Watch
• Subscription Required

On April 29, the FDA approved the use of once-daily Kaletra (lopinavir/ritonavir) 800 mg/200 mg for the treatment of HIV infection in therapy-naive adult patients. . . .

• June 1, 2005

New Guidelines on Managing Renal Disease in HIV-Infected Patients

• HIV/AIDS Clinical Care
• AIDS Watch
• Subscription Required

The HIV Medical Association has provided an up-to-date review on the epidemiology of — and clinical approach to — renal disease in HIV-infected patients. Included . . .

• May 11, 2005

HIV Treatment Guidelines Revised

• HIV/AIDS Clinical Care
• AIDS Watch
• Subscription Required

HIV treatment guidelines from DHHS/IDSA were recently updated to include the following:

• April 27, 2005

New Report Examines Ethical Issues Surrounding Tenofovir Pre-Exposure Prophylaxis Trials

• HIV/AIDS Clinical Care
• AIDS Watch
• Subscription Required

In March, the AIDS Vaccine Advocacy Coalition released a report on issues surrounding clinical testing of tenofovir for pre-exposure prophylaxis. Some of the trials of . . .

• April 13, 2005

Mortality Rate Increases Dramatically in South Africa

• HIV/AIDS Clinical Care
• AIDS Watch
• Subscription Required

During a recent 5-year period, the overall mortality rate in South Africa increased by 57%, from approximately 318,000 deaths in 1997 to 499,000 in 2002. . . .

• March 21, 2005

FDA Approves New Generic Formulations

• HIV/AIDS Clinical Care
• AIDS Watch
• Subscription Required

• By ACC Editors
• March 1, 2005